▶주메뉴 바로가기
▶본문 바로가기
[THE INVESTOR] Inflectra, Celltrion’s version of Johnson & Johnson’s Remicade, posted robust US sales growth in the first quarter, according to its distribution partner Pfizer’s financial report o...
[THE INVESTOR] The Financial Supervisory Service on May 1 concluded that Samsung BioLogics inflated its net profit for the fiscal year of 2015, just a year before its public listing on the country’s...
[THE INVESTOR] Huons said on April 30 that it has signed a contract worth 56.7 billion won (US$53.10 million) with Spanish dermo-cosmetics brand Sesderma to supply its self-developed botulinum toxin...
[THE INVESTOR] Chong Kun Dang Pharmaceutical said on April 27 it has been granted a patent covering the manufacturing process of its version of Kyowa Hakko Kirin and Amgen’s anemia drug Aranesp fro...
[THE INVESTOR] Korea’s pharmaceutical giant Celltrion has become a strong competitor to European and US drugs with its biosimilars, indicated by changes in sales, industry officials said on April 27...
[THE INVESTOR] Biogen has confirmed that it will make an additional investment worth 400 billion won (US$370 million) in Samsung Bioepis, a biosimilar developer and a joint venture between Samsung B...
[THE INVESTOR] LG Household & Health Care said on April 24 its affiliate will purchase a Japanese cosmetics firm for 10.5 billion yen (US$97.60 million) to expand its overseas business. Ginza St...
[THE INVESTOR] Cosmecca Korea, a local cosmetics maker, said on April 24 it has bought a US original design manufacturer in a 57.76 billion won (US$53.70 million) deal as it moves to expand its prese...
[THE INVESTOR] A total of 26 multinational drug companies donated a combined 25.9 billion won (US$24 million) in Korea in 2017, industry data showed on April 24. According to the data by the Kor...
[THE INVESTOR] Korean biopharmaceutical firm Celltrion said on April 20 it has won an approval from an Australian regulator for the sale of its biosimilar drug Truxima. The Therapeutic Goods Adm...
[THE INVESTOR] Korea’s Hanmi Pharmaceutical said on April 18 that it presented preclinical data of its three cancer therapy candidates at the annual meeting of the American Association of Cancer Res...
[THE INVESTOR] Korean security software provider AhnLab said on April 17 it has forged a partnership with Seoul National University Bundang Hospital for research on digital health care. Under the m...
[THE INVESTOR] Bayer Korea on April 17 announced the names of three startups who have been selected for its open innovation program in consultation with KOTRA. This is the second round of Grants4Ap...
[THE INVESTOR] South Korean drugmakers are rushing to roll out generic copies of Pfizer’s smoking cessation drug Champix, as the treatment’s substance patent here was recently broken by a local pate...
[THE INVESTOR] Humedix, a subsidiary of Huons Global , said on April 16 that it has obtained sales approval for two types of injection therapies that repair damaged skin and encourage wound healin...
L-Tree applies biometric technology to blockchain
Market Kurly operator secures W67b investment
Samsung's cooktops get high scores from U.S. Consumer Report
Two Samsung Group affiliates sell stake in Samsung C&T
KT ties up with firm behind Apple’s Siri for car infotainment systems
Samsung unveils triple-lens smartphone Galaxy A7
Parliament passes bill easing regulations on internet-only banks
Hanon Systems to acquire Magna’s fluid pressure and controls biz
September 26, 2018
